š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
In this study, the concentration of antibody to the vaccine one year, three...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-10-20
Trial ID
NCT00718666
Treatments Being Tested
Subjects were previously vaccinated at 11 to 17 years of age. This extensio...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-09
Trial ID
NCT00974363
Treatments Being Tested
This study evaluates the immunogenicity and safety of the meningococcal con...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-11-30
Trial ID
NCT01235975
Treatments Being Tested
The purpose of this study is to evaluate immunogenicity and safety of menin...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-01
Trial ID
NCT01144663
Treatments Being Tested
The purpose of the study is to characterize the immunogenicity \& safety of...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-02-13
Trial ID
NCT00614614
This study evaluates the immunogenicity and safety of the meningococcal con...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-01-27
Trial ID
NCT01340898
Treatments Being Tested
This study will investigate the long-term protection offered by GSK Biologi...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-02
Trial ID
NCT00390143
Treatments Being Tested
The purpose of the observer-blinded study is to determine the immunogenicit...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-08-27
Trial ID
NCT01154088
This study has 2 phases, a vaccination phase and a long-term follow-up phas...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-02-07
Trial ID
NCT00427908
Treatments Being Tested
Meningococcal disease is mostly caused by N. meningitidis of serogroups A, ...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-12-23
Trial ID
NCT00356369
Treatments Being Tested